Every material Form 8-K STEM, INC. has filed with the SEC since June 03, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Stem, Inc. received a non-compliance letter from the New York Stock Exchange on October 20, 2026, confirming it does not meet the NYSE requirement for average market capitalization and stockholders' equity of at least $50 million each. The company plans to submit a business plan to regain compliance within 18 months, and its common stock will continue trading on the NYSE during the cure period if the plan is accepted.
NYSE non-compliance letter received October 20, 2026; company notified NYSE October 19, 2026
Standard requires average market capitalization of at least $50 million over 30 trading days and stockholders' equity of at least $50 million
Business plan due within 45 days of receipt of the letter, with a target of regaining compliance within 18 months
Stock remains listed on the NYSE during the cure period, subject to NYSE acceptance of the plan and quarterly monitoring
Stem, Inc. reported results for the quarter ended June 30, 2026, with revenue down 12% year over year to $33.7 million and a net loss of $14.4 million, compared with net income of $202.5 million a year earlier that included a one-time gain on debt extinguishment. Adjusted EBITDA rose 63% to $6.2 million, and the company reaffirmed its full-year 2026 guidance across all metrics.
Revenue was $33.7 million, down from $38.4 million in Q2 2025, due to significantly reduced battery hardware resales and lower managed services revenue.
Software, services, and edge hardware revenue rose 1% to $33.4 million, with PowerTrack software revenue up 11% year over year.
Net loss was $14.4 million versus net income of $202.5 million in Q2 2025; the prior-year quarter included a one-time gain on extinguishment of debt.
Full-year 2026 guidance was reaffirmed, including revenue of $140 million to $190 million and adjusted EBITDA of $10 million to $15 million.
At its June 3, 2026 annual meeting, Stem stockholders re-elected three Class II directors, approved an amendment to the 2024 Equity Incentive Plan that adds 425,000 shares and extends the plan term, approved executive pay on an advisory basis, and ratified RSM US LLP as auditor for 2026. The plan increase expands the pool of shares available for equity awards, and the company filed the amended plan as Exhibit 10.
Plan amendment approved with 1,645,467 votes for, 387,942 against, 9,361 abstentions and 2,489,327 broker non-votes.
Director votes for: Ira Birns 1,977,507; Adam E. Daley 1,852,248; Anil Tammineedi 1,827,044. All nominees were elected to serve until the 2029 annual meeting.
RSM US LLP ratified as independent auditor for fiscal year ending December 31, 2026, with 4,330,718 votes for and 148,533 against.
About 4,532,097 shares, roughly 53% of shares entitled to vote, were present or represented by proxy.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every STEM, INC. filing is on SEC EDGAR ↗. 8-K briefs of other companies →